---
figid: PMC3106141__nihms285893f3
figtitle: Treating brain tumors with PDE4 Inhibitors
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC3106141
filename: nihms285893f3.jpg
figlink: /pmc/articles/PMC3106141/figure/F3/
number: F3
caption: Intracellular activation of AC converts ATP to cAMP resulting in modulation
  of activity in growth promoting pathways. Some of the multiple downstream cascades
  that regulate growth and are modulated by cAMP are shown. The majority of cAMP effects
  on signal transduction have been ascribed to cAMP-induced activation of PKA. However,
  PKA-independent actions of cAMP have also been demonstrated through specific activation
  of exchange proteins directly activated by cAMP (EPAC 1 and 2). Effects of cAMP
  are cell type-specific and often hinge upon differential expression of RAF isoforms.
  These critical regulators of the mitogen activated protein kinase (MAPK) pathway
  can either be stimulated by cAMP (RAF-B) or inhibited by cAMP (RAF-C). Prolonged
  stimulation of cAMP might cause transcriptional activation of targets such as AP-1
  and Lot-1, which can regulate cell survival, and repression of cell cycle regulators
  (e.g. cyclins and cyclin dependant kinases) leading to growth arrest. Finally, elevation
  of intracellular cAMP levels has also been shown to induce apoptotic cell death
  through PKA, protein kinase C (PKC), EPAC and Akt-mediated pathways.
papertitle: Treating brain tumors with PDE4 Inhibitors.
reftext: Rajarshi Sengupta, et al. Trends Pharmacol Sci. ;32(6):337-344.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9750578
figid_alias: PMC3106141__F3
figtype: Figure
redirect_from: /figures/PMC3106141__F3
ndex: b0feb1e3-dec0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3106141__nihms285893f3.html
  '@type': Dataset
  description: Intracellular activation of AC converts ATP to cAMP resulting in modulation
    of activity in growth promoting pathways. Some of the multiple downstream cascades
    that regulate growth and are modulated by cAMP are shown. The majority of cAMP
    effects on signal transduction have been ascribed to cAMP-induced activation of
    PKA. However, PKA-independent actions of cAMP have also been demonstrated through
    specific activation of exchange proteins directly activated by cAMP (EPAC 1 and
    2). Effects of cAMP are cell type-specific and often hinge upon differential expression
    of RAF isoforms. These critical regulators of the mitogen activated protein kinase
    (MAPK) pathway can either be stimulated by cAMP (RAF-B) or inhibited by cAMP (RAF-C).
    Prolonged stimulation of cAMP might cause transcriptional activation of targets
    such as AP-1 and Lot-1, which can regulate cell survival, and repression of cell
    cycle regulators (e.g. cyclins and cyclin dependant kinases) leading to growth
    arrest. Finally, elevation of intracellular cAMP levels has also been shown to
    induce apoptotic cell death through PKA, protein kinase C (PKC), EPAC and Akt-mediated
    pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Gpbar1
  - ac
  - Rapgef3
  - Akt1
  - ras
  - Hras
  - Kras
  - Rem1
  - Pik3r1
  - Src
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Terf2ip
  - Rap1a
  - Bcl2l11
  - Mdk
  - Braf
  - Ephb2
  - Mapk1
  - Cdkn1b
  - Dctn6
  - Psmd9
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Plagl1
  - Jun
  - Tas2r134
  - Rxfp2
  - Pik3cg
  - Prkcg
  - Ephb1
  - Tmed7
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - ATP8A2
  - RAPGEF3
  - RAPGEF4
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - AKT1
  - AKT2
  - AKT3
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - SRC
  - FGR
  - FYN
  - YES1
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK3
  - MAPK8
  - MAPK9
  - MAPK10
  - RAP1A
  - RABGEF1
  - TERF2IP
  - RAP1B
  - BCL2L11
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - BRAF
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - EPHB2
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - PLAGL1
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - FOSL1
  - FOSL2
  - Oamb
  - ATPsynbeta
  - Atpalpha
  - Epac
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Akt
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Src42A
  - Csk
  - Src64B
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - MKP-4
  - rl
  - Rap1
  - Dsor1
  - Mtk
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Erk7
  - DCTN6-p27
  - dap
  - CG9588
  - Lot-1
  - AP-1gamma
  - Jra
  - kay
  - Cancer
  - Lung cancer
---
